UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? | Dear UnitedHealth Stock …

Explore the latest developments concerning UnitedHealth Gears Up.

UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock?

UnitedHealth Group Incorporated UNH is set to report third-quarter 2026 results on Oct. 13, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $4.12 per share on revenues of $111.38 billion.

Third-quarter earnings estimates witnessed no movement over the past 60 days. The bottom-line projection indicates an improvement of 41.1% from the year-ago reported number. But the Zacks Consensus Estimate for quarterly revenues suggests a year-over-year decline of 1.6%.

For the current year, the Zacks Consensus Estimate for UnitedHealth's revenues is pegged at $446.78 billion, implying a decline of 0.2% year over year. However, the consensus mark for current-year earnings per share is pegged at $19.85, implying an improvement of 21.4% on a year-over-year basis.

UnitedHealth: A Beat Is Priced In, But There's Room For Surprise (NYSE:UNH)

UnitedHealth Group Incorporated (UNH) is heading into its Q3 print on 13th October. I find it interesting because its business is getting better while the stock is losing steam. They have already raised their

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

The dynamic landscape of current events often brings forth significant discussions. Monitoring these developments provides crucial insights.

For more detailed information, explore updates concerning UnitedHealth Gears Up.

For more news…

Comments

comments